Close Menu

Researchers at Children's Hospital Boston have published results proving that by taking the same factors that Takahashi and Yamanaka's groups did last year to reprogram mouse skin cells into induced pluripotent stem (iPS) cells, they could reprogram human cells to pluripotency. A news and views article looks at some of the limitations of their work.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.